Results 11 to 20 of about 6,444 (163)

Strain differences in cuprizone induced demyelination

open access: yesCell & Bioscience, 2017
Background Multiple sclerosis (MS) is a severe neurological disorder, characterized by demyelination of the central nervous system (CNS), and with a prevalence of greater than 2 million people worldwide.
Qili Yu   +6 more
doaj   +2 more sources

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination [PDF]

open access: yesMolecular Neurodegeneration, 2022
Background The dietary consumption of cuprizone – a copper chelator – has long been known to induce demyelination of specific brain structures and is widely used as model of multiple sclerosis.
Martin Zirngibl   +4 more
doaj   +4 more sources

Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.

open access: yesPLoS ONE, 2020
The cuprizone induced animal model of demyelination is characterized by demyelination in many regions of the brain with high levels of demyelination in the corpus callosum as well as changes in neuronal function by 4-6 weeks of exposure.
John Shelestak   +7 more
doaj   +2 more sources

Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics [PDF]

open access: yesFrontiers in Behavioral Neuroscience, 2010
Recent human studies suggest a role for altered oligodendrocytes in the pathophysiology of schizophrenia. Our recent animal study has reported some schizophrenia-like behaviors in mice exposed to cuprizone (Xu et al., 2009), a copper chelator that has ...
Haiyun Xu   +4 more
doaj   +2 more sources

Protective effects of erythropoietin against cuprizone-induced oxidative stress and demyelination in the mouse corpus callosum [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2017
Objective(s): Increasing evidence in both experimental and clinical studies suggests that oxidative stress plays a major role in the pathogenesis of multiple sclerosis.
Iraj Ragerdi Kashani   +7 more
doaj   +3 more sources

A New Model of Cuprizone-Mediated Demyelination/Remyelination

open access: yesASN Neuro, 2014
In the central nervous system, demyelinating diseases, such as multiple sclerosis, result in devastating long-term neurologic damage, in part because of the lack of effective remyelination in the adult human brain.
Hilary H. Sachs   +4 more
doaj   +2 more sources

Treadmill Exercise Impact on Brain Electrophysiological and Glial Immunoreactivity in Cuprizone-Treated Rats

open access: yesBrain Sciences
Background/Objectives: Demyelination occurs to a variable extent in various neurological diseases, such as multiple sclerosis. Physical exercise benefits central neural functions that depend on the brain’s electrophysiological and glial activity.
Cássia Borges Lima-de-Castro   +5 more
doaj   +2 more sources

Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model. [PDF]

open access: yesPLoS ONE, 2016
Cuprizone administration in mice provides a reproducible model of demyelination and spontaneous remyelination, and has been useful in understanding important aspects of human disease, including multiple sclerosis.
Ian Tagge   +9 more
doaj   +2 more sources

Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. [PDF]

open access: yesPLoS ONE, 2011
Vitamin D is emerging as a probably important environmental risk factor in multiple sclerosis, affecting both susceptibility and disease progression. It is not known to what extent this effect is due to a modulation of peripheral lymphocyte function, or ...
Stig Wergeland   +5 more
doaj   +3 more sources

Betaine Attenuates Cuprizone-Induced Cortical Demyelination: The Role of the WNT4/mTOR Signalling Pathway in Regulating Astrogliosis and Synaptic Integrity. [PDF]

open access: yesJ Biochem Mol Toxicol
Betaine helps to restore the dysfunctional communication between oxidative stress and inflammation, and it also improves demyelination in cuprizone‐induced demyelinating disease within the cerebral cortex. ABSTRACT Cortical grey matter pathology manifests early demyelinating diseases and is a primary driver of permanent neurological impairment.
Said YM   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy